B. Reidy

ORCID: 0009-0001-9260-9213
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Airway Management and Intubation Techniques
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Blood donation and transfusion practices
  • Abdominal vascular conditions and treatments
  • Cardiac Arrhythmias and Treatments
  • Tracheal and airway disorders
  • Liver Disease and Transplantation
  • Pediatric Hepatobiliary Diseases and Treatments
  • Blood transfusion and management
  • Atrial Fibrillation Management and Outcomes
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Vascular Anomalies and Treatments

Royal North Shore Hospital
2025

The University of Sydney
2025

Papworth Hospital
2024

Mater Misericordiae University Hospital
2022-2023

Abstract Background The role of aprotinin in modern cardiac surgery is not well defined. While licensed for use isolated coronary artery bypass grafting it more commonly used cases deemed to be at an increased risk bleeding. relative efficacy, and safety profile, as compared other antifibrinolytics these high‐risk uncertain. Study Design Methods A retrospective observational study with propensity matching determine whether versus tranexamic acid reduced bleeding or transfusion requirements...

10.1111/trf.17819 article EN Transfusion 2024-04-06

Airway stents are primarily inserted for the management of airway obstruction associated with an inoperable malignancy and rarely indicated in benign disease. We outline complications tracheal describe use veno-venous extracorporeal membrane oxygenation (V-V ECMO) to facilitate open surgery apnoeic patient who had uncovered metallic stent left place inappropriately long period. Computerised tomography imaging neck thorax provided information operative planning described addition extensive...

10.1016/j.bjao.2022.100011 article EN cc-by-nc-nd BJA Open 2022-05-18

Summary In this case report, we present a rare of life‐threatening gastrointestinal haemorrhage associated with deranged coagulation due to supratherapeutic levels dabigatran. Dabigatran is potent, synthetic, reversible non‐peptide thrombin inhibitor which increasingly used for stroke prevention in patients non‐valvular atrial fibrillation. It generally accepted that dabigatran dosing does not require titration or the monitoring plasma its predictable pharmacokinetics and pharmacodynamics....

10.1002/anr3.12208 article EN Anaesthesia Reports 2023-01-01
Coming Soon ...